share_log

Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition

Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition

大麻股Tilray加強在加拿大的大麻投資組合,贏得了國際烈酒競賽。
Benzinga ·  06/06 22:39

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Thursday the launch of 'Purple Churro,' by Redecan cannabis.

Tilray Brands公司(NASDAQ: TLRY)(TSX: TLRY)週四宣佈Redecan大麻推出“Purple Churro”。

The new sativa offers "a sweet, indulgent experience with a potent twist and boasting THC levels," the Canadian cannabis giant said in a press release.

這款新的半夏草提供“一種又甜又奢華的體驗,具有強效的THC含量”,這家加拿大的大麻巨頭在新聞稿中說。

Purple Churro is a cross of Cinnamon Horchata and Apples & Bananas, featuring a blend of sweet vanilla and cinnamon-tasting notes.

紫色西班牙麪包的交叉種是肉桂西班牙甜水糯米和蘋果香蕉,散發着甜香的香草和肉桂的味道。

The new strain is available in 3.5g and 14g dried flower formats in Ontario, Alberta and coming soon in Manitoba and British Columbia. Additional expansion across Canada is expected in the months to come.

在安大略省、艾伯塔省的3.5g和14g乾花格式上市,並計劃於不久的將來在馬尼托巴省和不列顛哥倫比亞省推出。預計在未來幾個月內將在加拿大的其他地區展開。

Meanwhile, Tilray's liquor business is celebrating two wins at the 15th annual New York International Spirits Competition. Tilray's subsidiary Breckenridge Distillery was a winner at Colorado American Blended Whiskey Distillery of the Year and Double Gold for Breckenridge Port Cask Finish.

與此同時,Tilray的酒業務在第15屆紐約國際烈酒大賽上獲得兩個獎項。Tilray的子公司Breckenridge Distillery在科羅拉多州美國調和威士忌酒廠獲得了年度蒸餾廠大獎和雙金獎。

"Breckenridge Distillery continues to be one of the most highly awarded craft distilleries in the U.S.," said Bryan Nolt, founder and CEO of Breckenridge Distillery. "Our continued recognition is a testament of our devotion to quality, taste and passion for whiskey."

Breckenridge酒廠的創始人兼首席執行官Bryan Nolt表示:“Breckenridge酒廠一直是美國最高榮譽的精釀酒廠之一。我們的持續認可證明了我們對品質、口感和威士忌的熱愛。”

See also: Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

請查看:大麻衍生品市場:爲什麼Tilray認爲大麻威士忌是一塊接受度高的金礦

Irwin D. Simon, chairman and CEO at Tilray, explained earlier why the company opted to diversify and venture into spirits and beverage markets.

Tilray的董事長兼首席執行官Irwin D. Simon之前解釋了爲什麼公司選擇多元化和進軍烈酒和飲料市場。

Tilray does not sell marijuana products in the U.S. because it's illegal on the federal level, which is why the company has expanded its U.S. focus to spirits, beer and food in addition to its medical marijuana operations in Europe, he said in an interview last year.

由於聯邦法令禁止在美國銷售大麻產品,因此該公司已擴大其美國業務重點,除了在歐洲開展醫療大麻業務外,還進軍烈酒、啤酒和食品市場。上年度接受採訪時稱,這樣做是爲了進行業務多元化。

The company recently filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC), under which it may offer and sell shares of its common stock having an aggregate offering value of up to $250 million from time to time through an at-the-market equity program. At the time Tilray said proceeds would help in leveraging anticipated regulatory changes in the U.S. cannabis sector among other things.

該公司最近向美國證券交易委員會(SEC)提交了一份招股說明書補充文件,根據該文件,公司可以通過“按市價配售股票計劃”不時提供並出售其普通股的價值總額高達2.5億美元。當時,Tilray表示這些收益將有助於在其他方面利用預期的美國大麻行業監管變化。

To learn more about cannabis stocks and investing come join us at upcoming Benzinga cannabis events.

了解更多大麻股票和投資信息,請加入即將到來的Benzinga大麻活動

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don't miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!

加入Benzinga大麻市場關注活動,於6月17日在新澤西!發展您的業務,爲龐大的新澤西娛樂市場籌集資金並受到好評。不要錯過在新不倫瑞克的此必見活動。現在立即預定您的門票。幾乎沒有位置剩餘。使用"JAVIER20"代碼可獲得20%折扣!

The 19th Benzinga Cannabis Capital Conference, is returning to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

第19屆Benzinga大麻資本大會將於今年10月8日至9日重新回到芝加哥。請通過以下鏈接獲取門票,以免票價上漲。

TLRY Price Action

TLRY股價

Tilray's shares traded 1.3966% lower at $1.765 per share at the time of writing on Thursday.

週四撰寫本文時,Tilray的股票價格爲每股1.765美元,下跌1.3966%。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論